Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients: A Randomized Controlled Trial

NCT01540240 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01540240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients: A Randomized Controlled Trial
Lead sponsor
University Hospital, Geneva
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2011
Completion date
Not reported
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, zidovudine adverse reaction